CRISPR Breakthroughs: Hope and Controversy in Medicine
Kilder
- Nature: Hope for diabetes: CRISPR-edited cells pump out insulin in a person – and evade immune detection - Nature
- Nature: First CRISPR horses spark controversy: what’s next for gene-edited animals? - Nature
- Nature: Pridopidine in early-stage manifest Huntington’s disease: a phase 3 trial - Nature
- Nature: Magnetically actuated multimodal bioelectronic catheter for minimally invasive surgery and sensing - Nature
- Statnews: Biotech VC raises $400 million ‘opportunity’ fund in sign of possible industry rebound - statnews.com
- Fiercebiotech: BioNTech's ADC beats Roche’s Kadcyla in breast cancer phase 3 - Fierce Biotech
Oppsummeringen og talen er laget med KI. Kildelenkene viser opphavet og er ikke en anbefaling av TellMe fra mediene.